Indian equity indices ended strong on Friday, with the NIFTY closing at 23,350.40, up 159.75 points (0.69%), while the Sensex ...

Haryana: Morepen Labs has announced that the Ministry of Corporate Affairs has approved the incorporation of 'QUICK MED ...

Experts recommend four stocks to buy or sell on Friday — Imagicaaworld Entertainment, Dhani Services, SJVN, and Morepen ...

On Wednesday, 3018 stocks advanced, 1033 declined and 115 remained unchanged, with an advance decline ratio of 2.92 on the ...

Morepen Labs has executed a Business Transfer Agreement (BTA) with Morepen Medtech for the transfer of its medical devices ...

The NSE Nifty 50 ended 1.45% higher at 22,834.30, while the BSE Sensex closed 1.53% up at 75,301.26 on Tuesday.

Morepen Laboratories Limited announces the launch of Empamore, a game-changing treatment for Type 2 Diabetes Mellitus, Heart ...

The uptick in the Morepen Labs share came after the company announced that it has rolled out ‘Empamore.’ Empamore is used to ...

Morepen Laboratories surged 8.90% to Rs 46.61 after the company launched Empamore, an affordable treatment for type 2 diabetes, heart failure, and chronic kidney disease in India.

Vedanta Chairman Anil Agarwal reaffirmed the company's commitment to unlocking value, saying the four new companies that will ...

Stocks like Raymond Lifestyle, Aditya Birla Real Estate, Samvardhana Motherson International, NBCC (India), Coffee Day ...

Pharmaceutical company Morepen Laboratories Ltd on Monday (March 17) said it has launched a new treatment for Type 2 diabetes, heart failure, and chronic kidney disease. The drug, Empamore, is said to ...